Attached files

file filename
10-Q - FORM 10-Q - ARRAY BIOPHARMA INCa9301510-q.htm
EX-31.1 - EXHIBIT 31.1 - ARRAY BIOPHARMA INCex31193015.htm
EX-31.2 - EXHIBIT 31.2 - ARRAY BIOPHARMA INCex31293015.htm
EX-10.5 - EXHIBIT 10.5 - ARRAY BIOPHARMA INCex105noncompete.htm
EX-10.7 - EXHIBIT 10.7 - ARRAY BIOPHARMA INCex107cantoramendmentno3.htm
EX-10.4 - EXHIBIT 10.4 - ARRAY BIOPHARMA INCex104employmentagreement.htm
EX-10.6 - EXHIBIT 10.6 - ARRAY BIOPHARMA INCex106confidentialityandinv.htm
EX-10.8 - EXHIBIT 10.8 - ARRAY BIOPHARMA INCex108comericatwelfthamendm.htm


Exhibit 32.1


CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with this quarterly report of Array BioPharma Inc. (the “Registrant”) on Form 10-Q for the period ended September 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(a)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.


Date:
November 5, 2015
/s/ RON SQUARER
 
 
Ron Squarer
 
 
Chief Executive Officer
 
 
 
 
 
 
 
 
/s/ MARY PATRICIA HENAHAN
 
 
Mary Patricia Henahan
 
 
Chief Financial Officer
 
 
(Principal Financial and Accounting Officer)